Literature DB >> 6214411

Polyclonal effect of HgCl2 in the rat, its possible role in an experimental autoimmune disease.

F Hirsch, J Couderc, C Sapin, G Fournie, P Druet.   

Abstract

Mercuric chloride induces an autoimmune glomerulonephritis in Brown-Norway (BN) but not in Lewis (LEW) rats. Injection of HGCl2 into BN rats regularly produced a transient appearance of plaque-forming cells (PFC) of anti-2,4,6-trinitrophenyl and anti-sheep red blood cell specificity and circulating anti-single-stranded DNA antibodies. Addition of HgCl2 to spleen cell cultures from BN rats induced an increase in anti-trinitrophenyl PFC and reverse PFC. This effect was no longer observed when nylon wool column-depleted or anti-Thy-1 antiserum-treated spleen cells were cultured in the presence of HgCl1. These data suggest that HgCl2 acts as a polyclonal activator on spleen cells in BN rats, but not on isolated B lymphocytes. In contrast, no effect of HgCl2 on immunoglobulin production was observed in LEW rats. Since polyclonal activation and immune-type nephritis are both seen in BN but not in LEW rats, polyclonal activation may participate in the pathogenesis of the HgCl2-induced autoimmune disease of BN rats.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6214411     DOI: 10.1002/eji.1830120716

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  45 in total

1.  Pretreatment of lymphocytes with mercury in vitro induces a response in T cells from genetically determined low-responders and a shift of the interleukin profile.

Authors:  H Hu; M Abedi-Valugerdi; G Möller
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

2.  Cyclosporin A in the prevention and treatment of experimental autoimmune glomerulonephritis in the brown Norway rat.

Authors:  J Reynolds; S J Cashman; D J Evans; C D Pusey
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

3.  Renal mechanisms in the cardiovascular effects of chronic exposure to inorganic mercury in rats.

Authors:  M Carmignani; P Boscolo; L Artese; G Del Rosso; G Porcelli; M Felaco; A R Volpe; G Giuliano
Journal:  Br J Ind Med       Date:  1992-04

4.  Single and combined effects of the vitamin D analogue KH1060 and cyclosporin A on mercuric-chloride-induced autoimmune disease in the BN rat.

Authors:  S T Lillevang; J Rosenkvist; C B Andersen; S Larsen; E Kemp; T Kristensen
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

5.  Kinetics and pathogenicity of autoantibodies induced by mercuric chloride in the brown Norway rat.

Authors:  C D Pusey; C Bowman; A Morgan; A P Weetman; B Hartley; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

6.  Mapping of a gene for the Mr 48,000 tubular basement membrane antigen in the rat.

Authors:  J C Guery; H J Hedrich; P Mercier; I C Reetz; C Mandet; P Mahieu; E G Neilson; P Druet
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

7.  Interleukin-2 production in Brown-Norway rats with HgCl2-induced autoimmune disease: paradoxical in vivo versus in vitro findings.

Authors:  D Baran; O Lantz; P Dosquet; A Sfaksi; P Druet
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

8.  Hyperactivity of donor B cells after neonatal induction of lymphoid chimerism in mice.

Authors:  M Goldman; D Abramowicz; P Lambert; P Vandervorst; C Bruyns; C Toussaint
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

9.  A central role for the mast cell in early phase vasculitis in the Brown Norway rat model of vasculitis: a histological study.

Authors:  Catherine S Vinen; David R Turner; David B G Oliveira
Journal:  Int J Exp Pathol       Date:  2004-06       Impact factor: 1.925

10.  Cyclosporin A induces long-term unresponsiveness in mercuric chloride-induced autoimmune glomerulonephritis.

Authors:  J Aten; C B Bosman; E De Heer; P J Hoedemaeker; J J Weening
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.